在1000个基因组小组中验证了多发性硬化症HLA风险等位基因的标记SNP
Anne I Boullerne1, Benjamin Goudey2, Julien Paganini3
1Department of Anesthesiology, University Illinois, Chicago, IL, USA.
Human immunology
|April 4, 2024
概括
大型组织相容性复合体中的遗传变异影响多发性硬化症 (MS) 风险. 这项研究验证了单核酸多态 (SNPs) 能够准确地识别不同种群中人类白细胞抗原 (HLA) 的等位基因.
科学领域:
- 免疫遗传学 免疫遗传学
- 人口遗传学 人口遗传学
- 人类疾病遗传学 人类疾病遗传学
背景情况:
- 主要基因相容性复合体 (MHC) 内的遗传变异与多发性硬化症 (MS) 风险密切相关.
- 关键的人类白细胞抗原 (HLA) 的等位基因包括DRB1*15:01,DRB1*15:03,DQB1*06:02和保护性A*02:01.01.
- 单核酸多态 (SNP) 经常被用来标记人类白细胞抗原 (HLA) 的等位基因,但它们在不同种群中的验证至关重要.
研究的目的:
- 评估19个单核酸多态 (SNP) 的标记性能,以识别与多发性硬化症 (MS) 风险相关的关键人类白细胞抗原 (HLA) 等位基因.
- 评估1000个基因组组内的不同种群中这些SNP的准确性.
- 在各种族群中确定可靠的人类白细胞抗原 (HLA) 等位基因归因的SNP.
主要方法:
- 研究的19个单核酸多态 (SNPs) 报告与特定的人类白细胞抗原 (HLA) 基因具有高链接不平衡 (LD).
- 利用了1000个基因组小组中的2,502名健康受试者的数据,并输入了人类白细胞抗原 (HLA) 数据.
- 使用链接不平衡R平方值,灵敏度,特异性和小等位基因频率来评估SNP性能.
主要成果:
- 少数单核酸多态 (SNPs) 在所有种群中显示了人类白细胞抗原 (HLA) 基因对标的高标记性能.
- 标记DRB1*15:01的SNP在欧洲和美国人群中表现出很高的表现,在英国人群中表现出完美的链接不平衡 (LD).
- rs3135388在南亚,美国和欧洲人群中显示了DQB1*06:02的高标记性能.
- rs2844821被确定为非洲 (包括非洲裔美国人) 和欧洲人群中A*02:01的高性能标签.
结论:
- 该研究确定了特定的单核酸多态 (SNP) 具有强大的标记性能的人类白细胞抗原 (HLA) 基因组在不同的人口.
- 这些发现为选择验证的SNP提供了基础,以准确评估人类白细胞抗原 (HLA) 对多发性硬化症 (MS) 风险和其他疾病的等位基因.
- 改进的SNP选择提高了不同祖先的遗传研究中人类白细胞抗原 (HLA) 基因归因的可靠性.
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K


